Alisa Lask

Alisa Lask

Director/Board Member at COLLPLANT BIOTECHNOLOGIES LTD.

Net worth: 4 020 $ as of 30/05/2026

55 year
Health Technology
Consumer Services
Consumer Non-Durables

Profile

Ms. Alisa Lask is a Chief Executive Officer & Director at Rion Aesthetics, Inc., a Chief Commercial Officer at Rion, Inc. and an Independent Director at CollPlant Biotechnologies Ltd. She is on the Board of Directors at Rion Aesthetics, Inc. and CollPlant Biotechnologies Ltd. Ms. Lask was previously employed as an Independent Director by RVL Pharmaceuticals Plc, an Independent Director by Nephros, Inc., a Vice President & General Manager-US Aesthetics by Galderma Laboratories LP, a Senior Director-Global Strategic Marketing by Allergan, Inc., a Vice President-Global Strategic Marketing by Zimmer Biomet, Inc., and a Director-Global Neuroscience by Eli Lilly & Co. She received her undergraduate degree from Miami University and an MBA from Stephen M.
Ross School of Business.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
17/03/2026 10,000 ( 0.07% ) 4 020 $ 30/05/2026

Alisa Lask active positions

CompaniesPositionStart
COLLPLANT BIOTECHNOLOGIES LTD. Director/Board Member 18/08/2021
Corporate Officer/Principal 31/10/2021
Chief Executive Officer 31/12/2021

Former positions of Alisa Lask

CompaniesPositionEnd
NEPHROS, INC. Director/Board Member 15/06/2025
RVL PHARMACEUTICALS PLC Director/Board Member 22/10/2023
Corporate Officer/Principal 31/05/2021
ALLERGAN, INC. Corporate Officer/Principal 31/05/2014
Corporate Officer/Principal 31/01/2010
See the detail of Alisa Lask's experience

Training of Alisa Lask

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

41

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Non-Durables